SE0200256D0 - New composition, methods and use - Google Patents

New composition, methods and use

Info

Publication number
SE0200256D0
SE0200256D0 SE0200256A SE0200256A SE0200256D0 SE 0200256 D0 SE0200256 D0 SE 0200256D0 SE 0200256 A SE0200256 A SE 0200256A SE 0200256 A SE0200256 A SE 0200256A SE 0200256 D0 SE0200256 D0 SE 0200256D0
Authority
SE
Sweden
Prior art keywords
methods
glutamine
new composition
git
alleviation
Prior art date
Application number
SE0200256A
Other languages
English (en)
Inventor
Stefan G Pierzynowski
Original Assignee
Gramineer Internat Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0104404A external-priority patent/SE0104404D0/sv
Application filed by Gramineer Internat Ab filed Critical Gramineer Internat Ab
Priority to SE0200256A priority Critical patent/SE0200256D0/sv
Publication of SE0200256D0 publication Critical patent/SE0200256D0/sv
Priority to AU2002359171A priority patent/AU2002359171A1/en
Priority to PCT/SE2002/002381 priority patent/WO2003055508A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0200256A 2001-12-21 2002-01-29 New composition, methods and use SE0200256D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0200256A SE0200256D0 (sv) 2001-12-21 2002-01-29 New composition, methods and use
AU2002359171A AU2002359171A1 (en) 2001-12-21 2002-12-19 Composition for the treatment of renal failure or gastric dysfunction of e.g. premature or neonatal mammals
PCT/SE2002/002381 WO2003055508A1 (en) 2001-12-21 2002-12-19 Composition for the treatment of renal failure or gastric dysfunction of e.g. premature or neonatal mammals

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0104404A SE0104404D0 (sv) 2001-12-21 2001-12-21 New methods and use
SE0200256A SE0200256D0 (sv) 2001-12-21 2002-01-29 New composition, methods and use

Publications (1)

Publication Number Publication Date
SE0200256D0 true SE0200256D0 (sv) 2002-01-29

Family

ID=26655637

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0200256A SE0200256D0 (sv) 2001-12-21 2002-01-29 New composition, methods and use

Country Status (3)

Country Link
AU (1) AU2002359171A1 (sv)
SE (1) SE0200256D0 (sv)
WO (1) WO2003055508A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL370937A1 (pl) * 2004-10-29 2006-05-02 Sgp & Sons Ab Preparat żywieniowy i/lub farmaceutyczny do stosowania w profilaktyce i leczeniu niedoborów wchłaniania mikroelementów z przewodu pokarmowego oraz zastosowanie preparatu farmaceutycznego jako czynnika stymulującego wchłanianie mikroelementów z przewodu pokarmowego do krwi
PL226695B1 (pl) * 2006-07-03 2017-08-31 Danuta Kruszewska Środek do zastosowania w zapobieganiu i/lub hamowaniu kolonizacji Helicobacter pylori, zastosowanie soli kwasu alfa‑ketoglutarowego z metalami alkalicznymi i ziem alkalicznych do wytwarzania środka leczniczego oraz dodatku do żywności do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori
SE0602446L (sv) * 2006-11-16 2008-05-17 Entress Ab Ny användning av kända farmakologiskt aktiva kemiska sammansättningar
CN102014888A (zh) * 2007-07-03 2011-04-13 达努塔·克鲁谢夫斯卡 α-酮戊二酸的新医药用途
CN111374222A (zh) * 2016-07-07 2020-07-07 中国农业大学 一种动物饲喂添加剂以及动物的饲喂方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0213099A3 (de) * 1985-08-23 1989-07-19 Cederroth Nordic Aktiebolag Mittel mit antiphlogistischer, immunstimulierender und zytoprotektiver Wirkung, ihre Herstellung und pharmazeutische Verwendungen
RU2084523C1 (ru) * 1993-10-06 1997-07-20 Государственный научный центр вирусологии и биотехнологии "Вектор" Способ получения питательной среды для культивирования лимфоцитов крови человека
US5962733A (en) * 1996-09-25 1999-10-05 Vets Plus, Inc. Glutamine containing electrolyte solution for calf scours
AU776783B2 (en) * 1999-07-09 2004-09-23 Sun Farm Corporation Method of treating malignancies and viral infections and improving immune function with a dietary supplement
US6372462B2 (en) * 1999-10-15 2002-04-16 Medmyco Ltd. Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms
NL1014380C2 (nl) * 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
US6376557B1 (en) * 2000-03-16 2002-04-23 Chanda Bhuwalka Zaveri Methods for treating alopecia

Also Published As

Publication number Publication date
WO2003055508A1 (en) 2003-07-10
AU2002359171A1 (en) 2003-07-15

Similar Documents

Publication Publication Date Title
DK0688214T3 (da) Fremgangsmåder til inhibering af knogletab med 3,4-diarylchroman
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
HUP0202570A1 (hu) Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
NO992400L (no) Nye substituerte pyrazolderivater
AU2002235930A1 (en) A process for the manufacture of a herbal composition comprising a matrine
HUP0102521A2 (hu) Sztilbénszármazékot és platina koordinációs vegyületet tartalmazó daganatellenes szer
ID26128A (id) Senyawa-senyawa aminotetralin tersubstitusi-n sebagai ligan-ligan untuk reseptor neupeptida y y5 yang bermanfaat dalam pengobatan obesitas dan gangguan-gangguan lain
RS50035B (sr) Farmaceutska kompozicija koja sadrži fenofibrat i postupak za njeno dobijanje
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
NO20060977L (no) Mitokinon-derivater anvendt som mitokondrielle malsokende antioksidanter
HRP20050103A2 (en) N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion
BRPI0315143B8 (pt) composto, composição farmacêutica, e, uso de um composto
TW200510367A (en) Novel lapachone compounds, their preparation, and the use thereof
NO985964D0 (no) Administrasjonskur for H+, K+ -ATPase-inhibitorer
ECSP045493A (es) Nuevas composiciones farmacéuticas que contienen flibanserina polimorfo a
SE0200256D0 (sv) New composition, methods and use
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
DE60123117D1 (de) Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs
NO995685D0 (no) Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasöytiske blandinger
WO2005082862A3 (en) Benzimidazolyl derivatives as kinase inhibitors
DE69718500D1 (de) (-)-enantiomere von cis-3,4-chromanderivaten zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen
UA81664C2 (ru) Производные дифенилмочевины и их применение, как блокаторов хлоридных каналов
NO996128L (no) Nye pentaerytrittderivater, deres fremstilling og anvendelse så vel som mellomprodukter for deres syntese